meglumine has been researched along with Ewing Sarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, HJA; Dammann, A; Dierckx, RAJO; Jutte, PC; Kasalak, Ö; Kwee, TC; Overbosch, J | 1 |
Bloem, JL; Hogendoorn, PC; Nooy, MA; Taminiau, AH; van der Woude, HJ; Verstraete, KL | 1 |
Fairclough, DL; Fletcher, BD; Gronemeyer, SA; Hanna, SL | 1 |
1 trial(s) available for meglumine and Ewing Sarcoma
Article | Year |
---|---|
Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Male; Meglumine; Neoplasm, Residual; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Sarcoma, Ewing | 1995 |
2 other study(ies) available for meglumine and Ewing Sarcoma
Article | Year |
---|---|
Surveillance MRI for the detection of locally recurrent Ewing sarcoma seems futile.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Retrospective Studies; Sarcoma, Ewing; Survival Rate | 2018 |
Pediatric musculoskeletal tumors: use of dynamic, contrast-enhanced MR imaging to monitor response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Soft Tissue Neoplasms | 1992 |